tiprankstipranks
Trending News
More News >
Apellis Pharmaceuticals (APLS)
:APLS
US Market

Apellis Pharmaceuticals (APLS) Ownership - Who Owns Apellis Pharmaceuticals?

Compare
894 Followers

Apellis Pharmaceuticals (APLS) Ownership Overview

3.43%21.41%38.59%14.97%21.59%
38.59% Other Institutional Investors
14.97% ETFs
21.59% Public Companies and Individual Investors
The ownership structure of Apellis Pharmaceuticals (APLS) stock is a mix of institutional, retail, and individual investors. Approximately 74.97% of the company’s stock is owned by Institutional Investors, 3.43% is owned by Insiders, and 21.59% is owned by Public Companies and Individual Investors.
The ownership structure of Apellis Pharmaceuticals (APLS) stock is a mix of institutional, retail, and individual investors. Approximately 60.00% of the company’s stock is owned by Institutional Investors, 3.43% is owned by Insiders, and 14.97% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 18, 2025
xxxxxxxxxxxxx
$4542
Mar 06, 2025
xxxxxxxxxxxxx
$139782
Feb 12, 2025
xxxxxxxxxxxxx
$10356
Jan 30, 2025
xxxxxxxxxxxxx
$24384

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$615334
Mar 31, 2025
xxxxxxxxxxxxx
$4786249

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
9,626,786Institution7.66%167,987,416
9,127,732Institution7.26%159,278,923
8,477,414Institution6.75%147,930,874
2,689,328Institution2.14%46,928,774
2,647,478Institution2.11%46,198,491
2,210,140Institution1.76%38,566,943
1,955,117Insider1.56%34,116,792
1,147,716Insider0.91%20,027,644
1,073,415Institution0.85%18,731,092
1,029,036Institution0.82%17,956,678

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
9,127,732Institution7.26%159,278,923
8,477,414Institution6.75%147,930,874
1,073,415Institution0.85%18,731,092
1,029,036Institution0.82%17,956,678
986,546Institution0.78%17,215,228
849,481Institution0.68%14,823,443
534,859Institution0.43%9,333,290
494,436Institution0.39%8,627,908
467,487Institution0.37%8,157,648
390,430Institution0.31%6,813,004

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,410,961Institution2.71%65,524,561
2,691,834Institution2.14%85,896,423
2,149,859Institution1.71%35,171,693
1,649,750Institution1.31%31,691,698
1,479,527Institution1.18%28,421,714
646,905Institution0.51%11,288,492
630,249Institution0.50%10,997,845
516,036Institution0.41%7,685,202
516,036Institution0.41%7,685,202
516,036Institution0.41%7,685,202

FAQ

Who Owns Apellis Pharmaceuticals (APLS)?
According to the latest TipRanks data, approximately 38.59% of the company's stock is held by institutional investors, 3.43% is held by insiders, and 21.59% is held by retail investors.
    What percentage of Apellis Pharmaceuticals (APLS) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 38.59% of Apellis Pharmaceuticals (APLS) stock is held by institutional investors.
      What percentage of Apellis Pharmaceuticals (APLS) stock is held by retail investors?
      According to the latest TipRanks data, approximately 21.59% of Apellis Pharmaceuticals (APLS) stock is held by retail investors.
        Who owns the most shares of Apellis Pharmaceuticals (APLS)?
        Vanguard owns the most shares of Apellis Pharmaceuticals (APLS).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis